Table 2. Non-nucleoside reverse-transcriptase inhibitors.

Generic name	Brand name	FDA approval date
Nevirapine	Viramune	1996
Delavirdine	Rescriptor	1997
Efavirenz	Sustiva	1998
Etravirine	Intelence	2008
Extended-release Nevirapine	Viramune XR	2011
Rilpivirine	Edurant	2011
Doravirine	Pifeltro	2018

FDA, food and drug administration.